Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.
- Status
- RECRUITING
- Phase
- N/A
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
- Status
- RECRUITING
- Phase
- PHASE2
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
- Status
- TERMINATED
- Phase
- PHASE1
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
- Status
- RECRUITING
- Phase
- NA
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
- Status
- RECRUITING
- Phase
- PHASE1
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
- Status
- RECRUITING
- Phase
- NA